Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
HUMA
HUMA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HUMA News
Biotech Sector Sees Surge in FDA and Global Approvals
Jun 12 2026
NASDAQ.COM
Humacyte Prices Public Offering to Raise $50M
Jun 11 2026
seekingalpha
Stock Futures Rebound as Navan Reports Strong Earnings
Jun 11 2026
seekingalpha
Humacyte Reports Positive Interim Results for ATEV in Phase 3 Study
Jun 11 2026
NASDAQ.COM
Humacyte Prices Public Offering at $1.05 per Share
Jun 11 2026
Newsfilter
Humacyte Initiates Underwritten Public Offering
Jun 11 2026
Yahoo Finance
Humacyte Announces Plans for FDA-Approved Product Sales
Jun 10 2026
stocktwits
Humacyte Reports Positive Clinical Trial Results Amid Stock Offering
Jun 10 2026
Yahoo Finance
Halper Sadeh LLC Investigates Humacyte Executives' Fiduciary Duties
Jun 05 2026
PRnewswire
Humacyte (HUMA) Q1 2025 Earnings Transcript
Jun 01 2026
NASDAQ.COM
Humacyte Reports Significant First Quarter Sales Growth
May 13 2026
Yahoo Finance
Humacyte Q1 Earnings Beat Expectations Despite Revenue Miss
May 13 2026
seekingalpha
Humacyte to Announce Q1 Earnings on May 13
May 12 2026
seekingalpha
Humacyte Realigns International Rights to Symvess Bioengineered Tissue
Apr 24 2026
NASDAQ.COM
Humacyte Regains Exclusive Rights for Symvess Outside the U.S.
Apr 24 2026
seekingalpha
Halper Sadeh LLC Investigates Humacyte Executives' Fiduciary Duties
Apr 09 2026
PRnewswire
Show More News
